Prepn: G. A. Archer et al., BE 629005 C.A. 60, 15896f (1964); NL 6401335 C.A. 62, 5289a (1965); G. A. Archer et al., US 3299053 (1963, 1964, 1967 all to Hoffmann-La Roche). Manuf process: R. Fryer, L. H. Sternbach, US 3567710 (1971 to Hoffmann-La Roche). Synthesis: S. Inaba et al., Chem. Pharm. Bull. 19, 263 (1971). Structure-activity studies: L. H. Sternbach et al., J. Med. Chem. 8, 815 (1965); Armagnac et al., Therapie 26, 439 (1971). Metabolism: Schwartz et al., J. Med. Chem. 11, 770 (1968); eidem, J. Pharm. Sci. 59, 1800 (1970). Pharmacology: L. O. Randall et al., Arch. Int. Pharmacodyn. Ther. 178, 216 (1969). Toxicology: H. C. Rosenberg, Pharmacol. Biochem. Behav. 13, 415 (1980). GC determn in plasma: Z. Salama et al., Arzneim.-Forsch. 38, 400 (1988). Comprehensive description: B. C. Rudy, B. Z. Senkowski, Anal. Profiles Drug Subs. 3, 307-331 (1974).
Sedative, hypnotic.
Sedative/Hypnotic; Benzodiazepine Derivatives